Metraipolis › archive › dc_2eaf844e8347

Real-world therapeutic strategies in active adult-onset Still's disease: clinical insights from the GIRRCS-AOSD study group — Europe PMC PMID:42620353

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42620353
DOI
10.3389/fimmu.2026.1852661
License (as archived)
solo-consultazione
Archived
2026-10-08T10:13:54.999Z
SHA-256 of the archived text
6ab623e951f5c9860efce0ab7ebea7a31c1fba2da009c9f0a3dd74cdb1d2ff4d
Stable URL of this page
https://metraipolis.com/documento/dc_2eaf844e8347

How to cite

Real-world therapeutic strategies in active adult-onset Still's disease: clinical insights from the GIRRCS-AOSD study group — Europe PMC PMID:42620353 — Europe PMC (en), https://europepmc.org/article/MED/42620353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2eaf844e8347 (Metraipolis archive dc_2eaf844e8347, sha256 6ab623e951f5c9860efce0ab7ebea7a31c1fba2da009c9f0a3dd74cdb1d2ff4d)
BibTeX
@misc{dc2eaf844e8347,
  title = {Real-world therapeutic strategies in active adult-onset Still's disease: clinical insights from the GIRRCS-AOSD study group — Europe PMC PMID:42620353},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42620353},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2eaf844e8347; sha256 6ab623e951f5c9860efce0ab7ebea7a31c1fba2da009c9f0a3dd74cdb1d2ff4d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42620353. Agents can read the archived copy with the MCP tool read_document.